Chuntao Wu

Chuntao Wu

Vertex Pharmaceuticals - Boston / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 4613855
-
person_outline Chuntao Wu's MOST POPULAR ARTICLES
1-) Estimating the relative risk in cohort studies and clinical trials of common outcomesLA McNutt, C Wu, X Xue, JP HafnerAmerican journal of epidemiology 157 (10), 940-943, 200320422003
2-) Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent eraEL Hannan, M Racz, DR Holmes, SB King III, G Walford, JA Ambrose, ...Circulation 113 (20), 2406-2412, 2006748*2006
3-) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary diseaseEL Hannan, C Wu, G Walford, AT Culliford, JP Gold, CR Smith, ...New England Journal of Medicine 358 (4), 331-341, 20086882008
4-) Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates?EL Hannan, C Wu, TJ Ryan, E Bennett, AT Culliford, JP Gold, A Hartman, ...Circulation 108 (7), 795-801, 20032592003
5-) Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomesEL Hannan, C Wu, G Walford, DR Holmes, RH Jones, S Sharma, SB KingJACC: Cardiovascular Interventions 2 (1), 17-25, 20092562009